Yaqrit prepares phase 3 for ammonia scavenger in hepatic encephalopathy
Acute and chronic treatment for hepatic encephalopathy acquired from Mallinckrodt Pharmaceuticals in September 2024Extended pre-clinical, clinical and IP package includes FDA and EMA orphan drug and ...